Tag: #influenza

Preprint: Closed-loop AI system discovers broadly neutralizing antibodies that protected mice from H1N1

Chinese preprint reports 'ImmuneAgent,' a closed-loop AI‑lab system that found broadly neutralizing antibodies from unsorted human B cells; some protected mice. Not peer‑reviewed.

#ai, #antibodies, #influenza, #preprint

FDA approves Moderna’s first seasonal mRNA flu vaccine — full approval for 50–64, accelerated OK for 65+

FDA approved Moderna’s mRNA-1010 seasonal flu vaccine (mFLUSIVA), giving full approval for ages 50–64 and accelerated approval for 65+, pending a confirmatory study.

$MRNA, #moderna, #influenza, #fda, #vaccines